Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?

OBJECTIVE: To compare the incidence of complicated cholelithiasis in patients receiving ritonavir-boosted atazanavir (ATV/r)- containing antiretroviral therapy with those on other protease inhibitors (PIs). DESIGN: We conducted a single-center retrospective cohort study of patients who started eithe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Yohei, Nishijima, Takeshi, Komatsu, Hirokazu, Teruya, Katsuji, Gatanaga, Hiroyuki, Kikuchi, Yoshimi, Oka, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713059/
https://www.ncbi.nlm.nih.gov/pubmed/23875004
http://dx.doi.org/10.1371/journal.pone.0069845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713059/
https://www.ncbi.nlm.nih.gov/pubmed/23875004
http://dx.doi.org/10.1371/journal.pone.0069845

Ejemplares similares